Journal of Controlled Release 2018
8 papers
The 2018 edition of the Journal of Controlled Release emphasized multifunctional drug delivery systems and advanced imaging techniques for oncology and localized therapies. Research focused on stimulus-responsive platforms, such as reduction/oxidation-responsive docetaxel prodrugs utilizing albumin-hitchhiking for breast cancer treatment. Other studies explored self-induced stimulus amplification to address multidrug resistance and lung metastasis. The integration of diagnostics and therapeutics was a recurring theme, exemplified by the development of zinc phthalocyanine-soybean phospholipid complexes for switchable photoacoustic and fluorescence imaging combined with photothermal and photodynamic therapies.
In addition to oncology, the journal featured developments in localized delivery methods, including intravitreal protein delivery to the retina and the evaluation of durable versus deployable coatings for stent-based drug release. Quantitative imaging of receptor-ligand engagement in live animals and critical appraisals of nanomedicines for early lung cancer detection highlighted the year's focus on improving clinical transition and diagnostic precision. Prolific contributors during this period included researchers such as Zhenqing Hou, Yang Li, and Xuan Zhu, whose work reflected the broader trend toward hyperselective and synergetic therapeutic strategies.
Top Authors
| Author | Papers |
|---|---|
| Margarida Barroso | 1 |
| Wei Wei | 1 |